
    
      PROTOCOL OUTLINE: This is a randomized, multicenter study. Patients are randomized to receive
      cyclophosphamide IV over 60 minutes on days -5 to -2 with or without antithymocyte globulin
      IV over 4 hours.

      All patients then receive bone marrow over 60-120 minutes on day 0, 36 hours after the last
      dose of cyclophosphamide.

      Patients are followed at day 100, at 6 months, and at 1 year posttransplant.
    
  